HRP20080173T3 - IMIDAZOLE DERIVATIVES AND THEIR USE IN THE TREATMENT OF mGluR5 RECEPTOR MEDIATED DISORDERS - Google Patents
IMIDAZOLE DERIVATIVES AND THEIR USE IN THE TREATMENT OF mGluR5 RECEPTOR MEDIATED DISORDERSInfo
- Publication number
- HRP20080173T3 HRP20080173T3 HR20080173T HRP20080173T HRP20080173T3 HR P20080173 T3 HRP20080173 T3 HR P20080173T3 HR 20080173 T HR20080173 T HR 20080173T HR P20080173 T HRP20080173 T HR P20080173T HR P20080173 T3 HRP20080173 T3 HR P20080173T3
- Authority
- HR
- Croatia
- Prior art keywords
- alkyl
- treatment
- imidazole derivatives
- receptor mediated
- mediated disorders
- Prior art date
Links
- RAXXELZNTBOGNW-UHFFFAOYSA-N 1H-imidazole Chemical class C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 title 1
- 102000012777 Metabotropic Glutamate 5 Receptor Human genes 0.000 title 1
- 108010065028 Metabotropic Glutamate 5 Receptor Proteins 0.000 title 1
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 title 1
- 230000001404 mediated effect Effects 0.000 title 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 4
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 150000002431 hydrogen Chemical class 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 1
- 125000006374 C2-C10 alkenyl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03014512 | 2003-07-03 | ||
| PCT/EP2004/007177 WO2005003117A1 (en) | 2003-07-03 | 2004-07-01 | Imidazole derivatives iii |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20080173T3 true HRP20080173T3 (en) | 2008-06-30 |
Family
ID=33560749
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20080173T HRP20080173T3 (en) | 2003-07-03 | 2008-04-15 | IMIDAZOLE DERIVATIVES AND THEIR USE IN THE TREATMENT OF mGluR5 RECEPTOR MEDIATED DISORDERS |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US7091222B2 (xx) |
| EP (1) | EP1644351B1 (xx) |
| JP (1) | JP4571631B2 (xx) |
| KR (1) | KR100719653B1 (xx) |
| CN (1) | CN100562520C (xx) |
| AR (1) | AR044973A1 (xx) |
| AT (1) | ATE388145T1 (xx) |
| AU (1) | AU2004253657B2 (xx) |
| BR (1) | BRPI0412158A (xx) |
| CA (1) | CA2531210C (xx) |
| CO (1) | CO5660258A2 (xx) |
| DE (1) | DE602004012268T2 (xx) |
| DK (1) | DK1644351T3 (xx) |
| ES (1) | ES2300789T3 (xx) |
| HR (1) | HRP20080173T3 (xx) |
| IL (1) | IL172821A (xx) |
| MX (1) | MXPA06000193A (xx) |
| MY (1) | MY142085A (xx) |
| NO (1) | NO20060112L (xx) |
| NZ (1) | NZ544454A (xx) |
| PL (1) | PL1644351T3 (xx) |
| PT (1) | PT1644351E (xx) |
| RU (1) | RU2360911C2 (xx) |
| SI (1) | SI1644351T1 (xx) |
| TW (1) | TWI252849B (xx) |
| WO (1) | WO2005003117A1 (xx) |
| ZA (1) | ZA200600026B (xx) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA80888C2 (en) * | 2003-06-05 | 2007-11-12 | Hoffmann La Roche | Imidazole derivatives as glutmate receptor antagonists |
| US7452909B2 (en) * | 2003-09-04 | 2008-11-18 | Hoffman-La Roche Inc. | Imidazole derivatives |
| EP1756086B1 (en) * | 2004-06-01 | 2008-06-04 | F.Hoffmann-La Roche Ag | Pyridin-4-yl-ethynyl-imidazoles and pyrazoles as mglu5 receptor antagonists |
| JP4690395B2 (ja) | 2004-06-01 | 2011-06-01 | エフ．ホフマン−ラ ロシュ アーゲー | ｍＧｌｕ５レセプターアンタゴニストとしてのピリジン−４−エチニル−イミダゾール及びピラゾール |
| US20060173048A1 (en) * | 2005-02-03 | 2006-08-03 | Mcarthur Silvia G | Imidazole derivatives |
| DE102005062987A1 (de) * | 2005-12-28 | 2007-07-05 | Grünenthal GmbH | Substituierte Propiolsäureamide und ihre Verwendung zur Herstellung von Arzneimitteln |
| AU2007336369B2 (en) | 2006-12-21 | 2013-01-17 | F. Hoffmann-La Roche Ag | Polymorphs of a mGluR5 receptor antagonist |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US304910A (en) * | 1884-09-09 | Robeet h | ||
| US4882343A (en) * | 1987-08-28 | 1989-11-21 | G. D. Searle & Co. | Biarylalkylimidazole derivatives as anti-depressants |
| TW544448B (en) * | 1997-07-11 | 2003-08-01 | Novartis Ag | Pyridine derivatives |
| US7531529B2 (en) * | 2003-06-05 | 2009-05-12 | Roche Palo Alto Llc | Imidazole derivatives |
-
2004
- 2004-06-23 US US10/874,948 patent/US7091222B2/en not_active Expired - Fee Related
- 2004-07-01 RU RU2006103009/04A patent/RU2360911C2/ru not_active IP Right Cessation
- 2004-07-01 WO PCT/EP2004/007177 patent/WO2005003117A1/en active IP Right Grant
- 2004-07-01 BR BRPI0412158-9A patent/BRPI0412158A/pt not_active IP Right Cessation
- 2004-07-01 AT AT04740542T patent/ATE388145T1/de active
- 2004-07-01 AR ARP040102312A patent/AR044973A1/es unknown
- 2004-07-01 KR KR1020067000075A patent/KR100719653B1/ko not_active IP Right Cessation
- 2004-07-01 CA CA2531210A patent/CA2531210C/en not_active Expired - Fee Related
- 2004-07-01 NZ NZ544454A patent/NZ544454A/en unknown
- 2004-07-01 CN CNB2004800200680A patent/CN100562520C/zh not_active Expired - Fee Related
- 2004-07-01 EP EP04740542A patent/EP1644351B1/en active Active
- 2004-07-01 DK DK04740542T patent/DK1644351T3/da active
- 2004-07-01 PT PT04740542T patent/PT1644351E/pt unknown
- 2004-07-01 AU AU2004253657A patent/AU2004253657B2/en not_active Ceased
- 2004-07-01 MX MXPA06000193A patent/MXPA06000193A/es active IP Right Grant
- 2004-07-01 PL PL04740542T patent/PL1644351T3/pl unknown
- 2004-07-01 TW TW093119915A patent/TWI252849B/zh not_active IP Right Cessation
- 2004-07-01 DE DE602004012268T patent/DE602004012268T2/de active Active
- 2004-07-01 SI SI200430679T patent/SI1644351T1/sl unknown
- 2004-07-01 ES ES04740542T patent/ES2300789T3/es active Active
- 2004-07-01 JP JP2006518089A patent/JP4571631B2/ja not_active Expired - Fee Related
- 2004-07-02 MY MYPI20042649A patent/MY142085A/en unknown
-
2005
- 2005-12-26 IL IL172821A patent/IL172821A/en not_active IP Right Cessation
- 2005-12-29 CO CO05131363A patent/CO5660258A2/es not_active Application Discontinuation
-
2006
- 2006-01-03 ZA ZA200600026A patent/ZA200600026B/en unknown
- 2006-01-06 NO NO20060112A patent/NO20060112L/no not_active Application Discontinuation
-
2008
- 2008-04-15 HR HR20080173T patent/HRP20080173T3/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MEP22008A (en) | Derivatives of n-[heteroaryl(piperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics | |
| HRP20080173T3 (en) | IMIDAZOLE DERIVATIVES AND THEIR USE IN THE TREATMENT OF mGluR5 RECEPTOR MEDIATED DISORDERS | |
| HRP20070529T3 (en) | Imidazole derivatives as glutmate receptor antagonists | |
| RS20060317A (xx) | Derivati n-/fenil(alkil-2-piperidin-2-il)metil/ benzamida postupak za njihovo dobijanje i njihova terapeutska primena | |
| RS50378B (sr) | N-heterociklični derivati kao nos inhibitori | |
| MXPA04006322A (es) | Derivados de 6-fluorobiciclo[3.1.0]hexano. | |
| MEP12608A (en) | Derivatives of n-[phenyl (pyrrolidine-2-yl) methyl]benzamide and n-[(azepan-2-yl)phenylmethyl]benzamide, preparation method thereof and application of same in therapeutics | |
| DK0862567T3 (da) | 5-azabicyclo[3.1.0]hexylalkyl-2-piperidoner og-glutarimider som neurokininreceptorantagonister | |
| SG169900A1 (en) | 4 - (3,4 - disubstituted phenyl) - pyrrolidin-2-one compounds as phosphodiesterase 4 inhibitors | |
| WO2003106428A8 (fr) | Derives d'arylsulfonamides et leur utilisation en tant que antagonistes au recepteur b1 de la bradykinine | |
| RS50932B (sr) | N-oksidi kao prolekovi 4-fenil-piridinskih derivata koji su antagonisti nk1 receptora | |
| NO20101069L (no) | Anvendelse av visse NMDA-affinitetsantagonister som antidepressiva | |
| HRP20090162T1 (en) | Quinolinone-carboxamide compounds as 5-ht4 receptor agonists | |
| NO20060206L (no) | Nye azetidinforbindelser | |
| EA200201259A1 (ru) | Производные бензимидазола, их получение и терапевтическое применение | |
| WO2002038565A3 (de) | 7-(r)-amino-triazolopyrimidine, deren herstellung und verwendung zur bekämpfung von pflanzenpathogenen pilzen | |
| HRP20070286T3 (en) | Substituted diketopiperazines and their use as oxytocyn antagonists | |
| WO2003031442A1 (fr) | Composes heterocycliques, derives oxazole, procede permettant de les presenter et leur utilisation | |
| DE60110896D1 (de) | Carboxamide und ihre verwendung als inhibitoren des mikrosomalen triglycerid-transfer-proteins und der apolipoprotein b (apo b) sekretion | |
| YU46787B (sh) | Derivati heteroaril 3-okso-propan-nitrila i postupak za njihovo dobijanje | |
| HRP20080363T3 (en) | Pyridin-4-yl-ethynyl-imidazoles and pyrazoles as mglu5 receptor antagonists | |
| DK0510003T3 (da) | Piperidin-og pyrrolidinderivater | |
| HRP20040230B1 (en) | Muscarinic agonists | |
| NO20082226L (no) | 6-heteroarylpyridoindolonderivater, deres fremstilling og terapeutisk anvendelse derav | |
| WO2003066621A8 (en) | Piperidine derivatives and their use as antagonists of tachykinins |